Disposable medical device sensors are emerging as powerful, cost-effective tools for diagnosing diseases, monitoring vital human parameters, and for various therapeutic applications.

The market is estimated at $61.60 billion in 2013 and is poised to grow at a CAGR of 6.2% from 2013 to 2018, to reach $83.21 billion by 2018.

The health IT security market is expected to witness high growth in coming years. The market size, in terms of value, is expected to reach USD 9,867.5 Million by 2020 from USD 4,905.9 Million in 2015, at a CAGR of 15.0%.

The injectable drug delivery technologies market is broadly categorized into two major segments, namely, devices technologies and formulation technologies.

The global market is poised for rapid growth between 2014 and 2019. The growth in pharmaceutical industry and government funding for drug discovery and life sciences are important reasons for the growth in market size.

The global HTS market was valued at an estimated $13,735.88 million in 2013 and is poised to grow at a CAGR of 7.4% from 2013 to 2018, to reach $19,626.54 million by 2018.

The market is valued at an estimated $3,831.6 million in 2013 and is poised to grow at a CAGR of 10.1% from 2013 to 2018, to reach $6,212.7 million by 2018.

The global human insulin market crossed $23 billion in 2013 and is poised to grow at a high double-digit CAGR from 2014 to 2019.

The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

The market was valued at $4,525 million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a CAGR of 10.5%.

This report studies the global radiation protection (detection, monitoring, and safety) market for medical applications over the forecast period of 2012 to 2017.

The global market is expected to reach USD 1,925.7 Million by 2020 from USD 1,271.8 Million in 2015, growing at a CAGR of 8.65%.

This report studies the global flow cytometry market over the forecast period of 2013-2018. The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period.

The market isestimated at $4,598.0 million in 2013 and is poised to grow at a CAGR of 10.6% from 2013 to 2018, to reach $7,609.3 million by 2018.

This market is poised to reach USD 59.15 Billion by 2020, growing at a CAGR of 33.4% during the forecast period.

The global nerve repair and regeneration market is valued at USD 5,945.69 Million in 2015. This market is expected to grow at a CAGR of 11.83% to reach USD 10,398.79 Million in 2020.

The global vital signs monitoring market was valued at $3,148 million in the year 2012 and is poised to grow at a CAGR of 6.61% from the year 2013, reaching approximately $4,375 million by 2018.

This report studies the global flow cytometry market over the forecast period of 2013-2018. The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

This report studies the global elemental analysis market for the forecast period of 2015 to 2020. This market is expected to reach $6.213 Billion by 2020 from $4.584 Billion in 2015, at a CAGR of 6.3%.

The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020

The global Wellness Supplements market is expected to reach USD 249.4 Billion by 2020 from USD 183.1 Billion in 2015, at a CAGR of 6.4% during the forecast period.

This report studies the global chromatography reagents market over the forecast period of 2013-2018.The market isestimated at $4,598.0 million in 2013 and is poised to grow at a CAGR of 10.6% from 2013 to 2018, to reach $7,609.3 million by 2018.

The market is segmented based on products, and types of insulin. Based on products, the global human insulin market is segmented into biologics and biobetters, and biosimilars/biogenerics.

The Global Platelet Aggregation Devices Market Is Poised to Reach $342.4 Million by 2020, Growing at a CAGR of 21.0% from 2015 to 2020

The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020.

This market was valued at $1,750.4 million in 2013 and is poised to grow at a CAGR of 29.8% from 2013 to 2018, to reach $6,459.0 million by 2018.

This report studies the European injectable drug delivery technologies market over the forecast period of 2015 to 2020.

The European Home Healthcare market has experienced extensive growth over the past few years, owing to rising aging population and technological advancements.

The global vital signs monitoring market was valued at $3,148 million in the year 2012 and is poised to grow at a CAGR of 6.61% from the year 2013, reaching approximately $4,375 million by 2018.

The global nerve repair and regeneration market is valued at USD 5,945.69 Million in 2015. This market is expected to grow at a CAGR of 11.83% to reach USD 10,398.79 Million in 2020.

The global human insulin market crossed $23 billion in 2013 and is poised to grow at a high double-digit CAGR from 2014 to 2019.

This report studies the global hematology instruments and reagents market over the forecast period of 2014 to 2019. The market is expected to reach $3.13 billion by 2019, at CAGR of 5.2% from 2014 to 2019.

This market is expected to reach USD 9.223 Billion by 2020 from USD 7.062 Billion in 2015, at a CAGR of 5.5%.

The ophthalmology devices market encompasses surgical devices which are used in cases of cataract, glaucoma, refractive errors, and vitreoretinal disorders; diagnostic and monitoring devices; and vision care products.

This report studies the global nucleic acid isolation market over the forecast period of 2013 to 2018. This market is valued at an estimated $2,103.39 million in 2013.

This report studies the global particle size analyzers market over the forecast period of 2013 to 2018. The market is expected to reach $290 million by 2018, at CAGR of 4.9% from 2013 to 2018.

The U.S. healthcare payer market has been greatly impacted by the introduction of the Patient Protection and Affordable Care Act (PPACA). This market is particularly driven by claims processing services.

The market was estimated at $642.0 million in 2012 and is poised to grow at a CAGR of 6.2% from 2012 to 2017 to reach $866.8 million by 2017.

The global radiation protection market, on the basis of industry, is classified into five segments, namely, medical, manufacturing, defense, nuclear power plants, and homeland security.

The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a CAGR of 10.5%.

This report studies the global stem cell therapy market over the forecast period of 2015 to 2020.The market is poised to grow at a CAGR of 39.5% from 2015 to 2020, to reach $330million by 2020.

This report studies the global flow cytometry market over the forecast period of 2013-2018. The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

The global human insulin market crossed $23 billion in 2013 and is poised to grow at a high double-digit CAGR from 2014 to 2019.

The global vital signs monitoring market was valued at $3,148 million in the year 2012 and is poised to grow at a CAGR of 6.61% from the year 2013, reaching approximately $4,375 million by 2018.

The future of genomics lies in the personalized medicine industry. Government initiatives and considerable investments are expected to drive genetic research on personalized medicines that utilize base pairs of the human genome sequence

The future of genomics lies in the personalized medicine industry. Government initiatives and considerable investments are expected to drive genetic research on personalized medicines that utilize base pairs of the human genome sequence”.

The U.S. healthcare payer, provider, and pharmaceutical outsourcing markets are valued at $11.1 billion, $6.8 billion, and $65.6 billion, respectively, in the year 2013.